Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Harvard Business School
Cipla
Deloitte
Chubb
Citi
QuintilesIMS
Queensland Health
UBS

Generated: December 18, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR QUETIAPINE FUMARATE

« Back to Dashboard

Clinical Trials for Quetiapine Fumarate

Trial ID Title Status Sponsor Phase Summary
NCT00034775 A Study to Assess Safety and Tolerabiltiy Associated With a Switch From Oral Antipsychotic Medications to Long-acting Injectable Risperidone in Patients With Schizophrenia. Completed Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Phase 3 The primary purpose of the study is to assess the safety and tolerability of a long-acting injectable formulation of risperidone when switching from an oral antipsychotic in patients with schizophrenia.
NCT00060489 Safety and Efficacy Trial of the Use of Quetiapine Fumarate (SEROQUEL®) in the Treatment of Patients With Bipolar Depression Completed AstraZeneca Phase 3 The purpose of this study is to evaluate the efficacy and safety of quetiapine in the treatment of a major depressive episode in patients with bipolar disorder.
NCT00081380 Efficacy and Safety of Seroquel Plus Mood Stabilizer in the Maintenance of Bipolar I Disorder Completed AstraZeneca Phase 3 The purpose of this study is to determine whether quetiapine when used as adjunct to lithium or divalproex is safe and effective in the maintenance treatment of adult patients with Bipolar I Disorder. The study consists of enrollment and 2 phases, the Open-label treatment Phase and the Randomized treatment Phase. PLEASE NOTE: Seroquel SR and Seroquel XR refer to the same formulation. The SR designation was changed to XR after consultation with FDA.
NCT00083954 Controlled Study of the Use of Quetiapine Fumarate in the Treatment of Patients With Bipolar Depression Completed AstraZeneca Phase 3 The purpose of this study is to determine the efficacy of quetiapine compared to placebo in the treatment for a major depressive episode in patients with bipolar disorder after receiving treatment for up to 8 weeks.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Quetiapine Fumarate

Condition Name

Condition Name for Quetiapine Fumarate
Intervention Trials
Schizophrenia 20
Major Depressive Disorder 11
Bipolar Disorder 11
Bipolar Depression 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Quetiapine Fumarate
Intervention Trials
Disease 27
Depression 24
Depressive Disorder 22
Schizophrenia 22
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Quetiapine Fumarate

Trials by Country

Trials by Country for Quetiapine Fumarate
Location Trials
United States 585
Canada 65
China 43
India 19
South Africa 16
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Quetiapine Fumarate
Location Trials
Texas 28
Florida 27
California 26
New York 26
Pennsylvania 24
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Quetiapine Fumarate

Clinical Trial Phase

Clinical Trial Phase for Quetiapine Fumarate
Clinical Trial Phase Trials
Phase 4 18
Phase 3 46
Phase 2 5
[disabled in preview] 9
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Quetiapine Fumarate
Clinical Trial Phase Trials
Completed 76
Unknown status 3
Terminated 2
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Quetiapine Fumarate

Sponsor Name

Sponsor Name for Quetiapine Fumarate
Sponsor Trials
AstraZeneca 59
Roxane Laboratories 3
Torrent Pharmaceuticals Limited 3
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Quetiapine Fumarate
Sponsor Trials
Industry 70
Other 21
NIH 3
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Federal Trade Commission
Baxter
Express Scripts
Colorcon
Julphar
Healthtrust
Mallinckrodt
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.